Pharmaceutical Advertising and Public Perceptions in Saudi Arabia
Mohammed A Alnuhait1, Hana A Althobaiti1, Meshari H Alharbi1
1Pharmaceutical Practices Department, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia.
Pharmacy (Basel, Switzerland)
|October 25, 2024
Summary
Public awareness of drug ads in Saudi Arabia is high, but concerns about unrealistic expectations and overmedication persist. Stricter regulations for pharmaceutical advertising, especially online, are strongly desired by consumers.
Area of Science:
- Pharmaceutical advertising
- Public health
- Digital marketing regulations
Background:
- The evolving digital landscape necessitates an examination of pharmaceutical advertising in Saudi Arabia.
- Understanding public awareness and perceptions is crucial for effective regulation.
Purpose of the Study:
- To assess public awareness and perceptions of medication advertisements in Saudi Arabia.
- To evaluate the influence of regulatory frameworks on public understanding and attitudes.
- To identify preferred advertising mediums and concerns regarding pharmaceutical ads.
Main Methods:
- A cross-sectional study utilizing an electronic survey conducted in Saudi Arabia (December 2023).
- A diverse sample of 440 participants completed the survey distributed via social media.
- The survey covered perceptions, attitudes, knowledge of regulations, and medium preferences for drug advertisements.
Main Results:
- High awareness of drug advertisements among participants (average age 33, primarily bachelor's degree holders).
- Significant concerns exist regarding unrealistic expectations (89.8%) and potential overmedication.
- A strong demand for stricter regulations (93.2%) and proactive monitoring (96.4%) of online pharmaceutical advertising, particularly on social media.
Conclusions:
- Pharmaceutical advertising in Saudi Arabia requires a balance between ethical transparency and educational value.
- Digital platforms necessitate enhanced regulatory oversight for accurate information dissemination.
- Aligning advertising practices with public health interests and regulatory standards is essential through collaboration.
Related Concept Videos
Pharmacovigilance
778
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
778
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact
144
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
144
Structure-Activity Relationships and Drug Design
622
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
622
Prescription, Nonprescription and Orphan Drugs
699
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
699
Drug Abuse and Addiction: Pharmacological Phenomena
445
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
445


